2019
DOI: 10.17116/jnevro201911909260
|View full text |Cite
|
Sign up to set email alerts
|

Clinical significance and possibilities of therapy of post-stroke depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 64 publications
0
4
0
Order By: Relevance
“…The preclinical study of Xiaoyao Jieyu San was a traditional Chinese medicine consisting of 11 components. By increasing 5-HT in PSD rats, the expression of norepinephrine and Brain-Derived Neurotrophic Factor (BDNF) werereduced, thereby reducing the degree of depression in PSD (Trusova and Levin, 2019).Spikes in glutamate levels in PSD were common, and giving pyruvate to experimental rats had been reported to limit the amount of glutamate to reduce symptoms of anxiety and depression (Pei et al, 2019).Studies had shown that aryl hydrocarbon receptor nuclear translocation protein 2 (ARNT2) could help neurons survive and have neural functions. The effect of ARNT2 in PSD rats may be a therapeutic target for further translational research (Hu et al, 2019;Rice et al, 2022).…”
Section: Group 1: Study Of Risk Factors For Depression After Strokementioning
confidence: 99%
“…The preclinical study of Xiaoyao Jieyu San was a traditional Chinese medicine consisting of 11 components. By increasing 5-HT in PSD rats, the expression of norepinephrine and Brain-Derived Neurotrophic Factor (BDNF) werereduced, thereby reducing the degree of depression in PSD (Trusova and Levin, 2019).Spikes in glutamate levels in PSD were common, and giving pyruvate to experimental rats had been reported to limit the amount of glutamate to reduce symptoms of anxiety and depression (Pei et al, 2019).Studies had shown that aryl hydrocarbon receptor nuclear translocation protein 2 (ARNT2) could help neurons survive and have neural functions. The effect of ARNT2 in PSD rats may be a therapeutic target for further translational research (Hu et al, 2019;Rice et al, 2022).…”
Section: Group 1: Study Of Risk Factors For Depression After Strokementioning
confidence: 99%
“…The intricate etiology of PSD encompasses socio-psychological dynamics, pathophysiological alterations, and myriad other contributory factors. This complexity underpins the prevailing absence of a coherent, efficacious clinical approach towards PSD, often culminating in suboptimal therapeutic outcomes for the afflicted ( Starkstein, Mizrahi & Power, 2008 ; Trusova & Levin, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…At present, post-stroke depression is mainly treated with antidepressants [9], but it is important to consider any potential side effects, including damage to the heart, gastrointestinal tract, sexual dysfunction, and sleep disturbances [10,11]. The study found that patients taking medications were characterized by a low compliance rate, long reaction time, strong dependence, and large adverse reactions (e.g., headache, nausea, excitement, decreased intellective acuity, loss of memory loss, gain in weight, and metabolic disturbance [12]).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, antidepressants do not fully respond to a large proportion of patients [14]. From the above problems, it can be inferred that poststroke depression is difficult to achieve complete remission by antidepressant treatment alone [9,10].Therefore, combining pharmacological and nonpharmacological therapies is essential. Traditional Chinese acupuncture rehabilitation is an effective nonpharmacological therapy for post-stroke depression because acupuncture has very good results in regulating depression and improving mood and sleep [15].…”
Section: Introductionmentioning
confidence: 99%